FAULDING Trademark

Trademark Overview


On Monday, May 18, 2015, a trademark application was filed for FAULDING with the United States Patent and Trademark Office. The USPTO has given the FAULDING trademark a serial number of 79169473. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, July 8, 2022. This trademark is owned by Symbion Pty Ltd. The FAULDING trademark is filed in the Pharmaceutical Products category with the following description:

Vitamins and vitamin preparations; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammation; pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for treating chemical imbalances; pharmaceutical preparations for treating irritable bowel syndrome; pharmaceutical preparations for treating urinary tra...
faulding

General Information


Serial Number79169473
Word MarkFAULDING
Filing DateMonday, May 18, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, July 8, 2022
Registration Number4872531
Registration DateTuesday, December 22, 2015
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 6, 2015

Trademark Statements


Goods and ServicesVitamins and vitamin preparations; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammation; pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for treating chemical imbalances; pharmaceutical preparations for treating irritable bowel syndrome; pharmaceutical preparations for treating urinary tract infections; pharmaceutical preparations for the treatment of immune system related diseases and disorders; preparations for treating colds; pharmaceutical products for the treatment of joint disease; dietary and nutritional supplements; dietary and nutritional supplements containing fish oil; dietary and nutritional supplements containing krill oil; probiotic supplements; ocular pharmaceuticals; herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain; herbal supplements; medicinal herbal extracts for medical purposes; natural herbal supplements; anti-arthritic compositions and preparations; topical analgesic creams; anti-inflammatory sprays; herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain; nutritional supplements for boosting energy, reducing stress, maintaining cardiovascular health, assisting cognitive function, assisting in the maintenance of normal blood pressure, relieving sleeplessness, reducing cholesterol and supporting healthy hair, skin and nails; nutraceuticals for use as a dietary supplement for liver support; menstrual symptom treatment preparations; calcium supplements; glucose dietary supplements; lysine preparations; medicinal herb extracts; dietary supplements consisting primarily of iron; medicated skin preparation for use in treating eczema; therapeutic agents for weight control and appetite suppression; urinary tract disinfectants; medicines for the treatment of gastrointestinal diseases; medicines for intestinal disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSymbion Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU

Party NameSymbion Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMELBOURNE VIC 3004
AU

Party NameSymbion Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMELBOURNE VIC 3004
AU

Trademark Events


Event DateEvent Description
Tuesday, May 9, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, April 20, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, April 20, 2023INVALIDATION PROCESSED
Wednesday, March 8, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, July 8, 2022CANCELLED SECTION 71
Thursday, August 9, 2018REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
Friday, August 3, 2018TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, October 6, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, June 23, 2016NOTIFICATION PROCESSED BY IB
Thursday, March 24, 2016FINAL DISPOSITION NOTICE SENT TO IB
Thursday, March 24, 2016FINAL DISPOSITION PROCESSED
Thursday, January 21, 2016GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, December 22, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, October 6, 2015PUBLISHED FOR OPPOSITION
Friday, October 2, 2015NOTIFICATION PROCESSED BY IB
Wednesday, September 16, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 16, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 16, 2015NOTICE OF PUBLICATION
Saturday, August 29, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 29, 2015ASSIGNED TO EXAMINER
Tuesday, August 11, 2015APPLICATION FILING RECEIPT MAILED
Wednesday, August 5, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 30, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB